# Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)

> **NCT00099515** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 97 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY041001 (HIIP)
- **DRUG:** LY041001 (HIIP)

## Key facts

- **NCT ID:** NCT00099515
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2007-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099515, "Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00099515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*